secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001641172-25-003271
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma closes $1.65M second tranche of Series C preferred & warrant offering
--------------------------------------------------------------------------------

- Second closing on April 8, 2025 raised $1.65M from sale of 1,650 Series C Convertible Preferred shares.
- Total offering raises $3.3M; preferred initially convertible into up to 5.63M common shares, warrants for 11.26M additional shares.
- Securities issued without registration under Section 4(a)(2) and Regulation D; proceeds for general corporate purposes.
- First closing of 1,650 shares occurred on February 13, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225003271/0001641172-25-003271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225003271/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer